ISPE Announces ISPE AI (TM), an Artificial Intelligence Initiative
Summary
NORTH BETHESDA, Md., Aug. 6, 2024 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) has announced ISPE AI (TM), a significant initiative aimed at aiding the pharmaceutical industry in realizing the potential of artificial intelligence (AI). "Recent advances in AI have brought attention to this rapidly accelerating technological innovation. "We are acutely aware of the needs and interest areas of our members and recognize the importance of supporting the pharmaceutical industry in the responsible advancement of AI." The new CoP will also build upon the endeavors of the ISPE GAMP® Artificial Intelligence/Machine Learning Special Interest Group, and ISPEs Pharma 4.0™ initiatives, which have been actively contributing to the industrys adoption of digitalization strategies and AI/machine learning (ML) technologies. "As a trusted leader in the pharmaceutical industry, ISPE is uniquely positioned to support this increased focus into the critical area of AI/ML.